Nt-probnp testing
Intervention1 paper2 findings
- In silico1
Outcomes
2Quality-adjusted life-years
upin silico1Very low certainty
1 study
Quality-adjusted life-years
upin silico1Very low certainty
Nt-probnp testing improves quality-adjusted life-years in silico (3.45 vs 2.84 QALYs).
In silicotype 2 diabetes
Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes · BMJ open diabetes research & care · 28 Sep 2026
Lifespan
upin silico1Very low certainty
1 study
Lifespan
upin silico1Very low certainty
Nt-probnp testing extends lifespan in silico (6.27 vs 4.99 LYs).
In silicotype 2 diabetes
Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes · BMJ open diabetes research & care · 28 Sep 2026